ArticleWorld journal of surgical oncology2022

Heparanase is a prognostic biomarker independent of tumor purity and hypoxia based on bioinformatics and immunohistochemistry analysis of esophageal squamous cell carcinoma.

Yu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.